Search
Close this search box.

CGTN:How China is creating new opportunities for building an Asia-Pacific community

CGTN published an article highlighting China’s renewed call to expand ways for the Asia-Pacific to prosper together. The article also examines how China’s own development creates a list of opportunities for economic growth across the region and beyond. SHENZHEN, China, Nov. 18, 2026 (GLOBE NEWSWIRE) — For Martin Chu, co-founder

CGTN:How China is creating new opportunities for building an Asia-Pacific community

CGTN published an article highlighting China’s renewed call to expand ways for the Asia-Pacific to prosper together. The article also examines how China’s own development creates a list of opportunities for economic growth across the region and beyond. SHENZHEN, China, Nov. 18, 2026 (GLOBE NEWSWIRE) — For Martin Chu, co-founder

EBC Launches Anthropic Pre-IPO CFD on MT5 Ahead of Expected Nasdaq Debut

ANT offers 24/7 pre-listing trading, long and short positions, and automatic transition to share CFDs, with limited-time promotional commission and overnight financing waivers LONDON, Nov. 18, 2026 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) has launched the Anthropic Pre-IPO contract for difference (CFD) on MetaTrader 5 (MT5), expanding its CFD

Global English Proficiency Declines for Fifth Consecutive Year, New Report Finds

EF English Proficiency Index 2026 reveals a world that can read English but struggles to speak it Zurich, Switzerland — 18 November 2026 — EF (Education First) today published the EF English Proficiency Index (EF EPI)2026, the world’s largest ranking of countries and cities by English proficiency. Based on data

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

– REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinically meaningful reduction in risk of death by 41% with median overall survival of 24.0 months versus 14.7 months for best available treatment, and a hazard ratio of 0.59 (p=0.035) – – Company plans to meet with

EAACI calls for allergy and respiratory health to be part of climate action at COP31

A dedicated symposium will connect scientific evidence, patient needs and climate policy, advancing EAACI’s vision of a future free from the burden of allergy and asthma. ZURICH, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI) will bring allergy and respiratory health into

Cairo ICT 2026: T-INNOWARE Debuts at Cairo ICT in Egypt, Secures Major Overseas Cooperation for AI Solutions

7-10 November 2026, Egypt International Exhibition Center, New Cairo Cairo ICT 2026 — the MEA region’s definitive technology event — attracting over 184,600 visitors NEW CAIRO, Egypt, Nov. 16, 2026 (GLOBE NEWSWIRE) — T-INNOWARE, Sinovatio’s Singapore-based wholly-owned subsidiary, showcased in Egypt its three-tier full-stack enterprise AI system covering governance layer,

About Us

Promoting revolutionary values and uniting movements for South Africa’s economic freedom.

Newsletter

Enter your email address below to subscribe to my newsletter